Literature DB >> 33592894

An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report.

Le Chang1,2, Jing Xiong1, Yuying Xue2, Jie Wang2, Xurong Zhu1, Xuejiao Zheng2, Xiaoyu Gao2, YuE Yan1, Jiaduo Hao2, Hehuan Zhao2, Zhengli Di1.   

Abstract

RATIONALE: The Miller Fisher syndrome (MFS) is an acute polyradiculoneuritis regarded as an uncommon clinical variant of the Guillain-Barre syndrome (GBS). It is characterized by the clinical triad of ophthalmoplegia, ataxia, and areflexia. The diagnosis of MFS is based on clinical presentation, presence of albuminocytologic dissociation in the cerebrospinal fluid (CSF), and normal brain imaging results. The presence of anti-ganglioside antibodies (GQlb) in the serum is helpful for the diagnosis. A history of upper respiratory tract infection or diarrhea 3 days to 6 weeks before the onset of MFS is common. However, there are some patients with atypical manifestations who are difficult to diagnose. Here, we present an incomplete form of MFS where antibodies against GQ1b were detected in the serum following an Epstein Barr virus (EBV) infection. PATIENT CONCERNS: A 77-year-old Chinese woman was admitted to the hospital with acute diplopia and right blepharoptosis. She had a history of mild upper respiratory tract infection 2 weeks ago. In 1 week, the symptoms rapidly progressed into bilateral ophthalmoplegia and hyporeflexia of the limbs without ataxia. CSF analysis on the third day after onset was normal, without albuminocytologic dissociation. EBV immunoglobulin G (IgG) antibodies were detected in the CSF. GQ1b and GD1b IgG antibodies were positive in the serum and negative in the CSF. No responsible lesion was found on brain imaging examination. DIAGNOSES: In accordance with the progressive bilateral ophthalmoplegia and hyporeflexia, the history of upper respiratory tract infection, the detection of EBV and GQ1b antibodies, and the negative brain imaging examination, the diagnosis of MFS was confirmed.
INTERVENTIONS: The patient was administered intravenous immunoglobulin for 5 days. OUTCOMES: She had a favorable outcome after treatment. At the 6-week follow-up, bilateral ocular movement limitation and tendon reflexes had recovered. LESSONS: The diagnosis of MFS can be challenging, especially when encountered with incomplete symptoms and normal CSF results. Attention should be paid to the presence of anti-GQ1b IgG antibodies when the clinical manifestations are incomplete. Furthermore, EBV primary infection could be associated with MFS and considered a potential causative agent.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33592894      PMCID: PMC7870176          DOI: 10.1097/MD.0000000000024451

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  21 in total

1.  An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia).

Authors:  M FISHER
Journal:  N Engl J Med       Date:  1956-07-12       Impact factor: 91.245

2.  Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.

Authors:  A Chiba; S Kusunoki; T Shimizu; I Kanazawa
Journal:  Ann Neurol       Date:  1992-06       Impact factor: 10.422

3.  Clinical features and prognosis of Miller Fisher syndrome.

Authors:  M Mori; S Kuwabara; T Fukutake; N Yuki; T Hattori
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

Review 4.  Guillain-Barré Syndrome.

Authors:  Eelco F M Wijdicks; Christopher J Klein
Journal:  Mayo Clin Proc       Date:  2017-03       Impact factor: 7.616

5.  The complement story in Guillain-Barré syndrome: from pathogenesis to therapy.

Authors:  Eduardo Nobile-Orazio
Journal:  Lancet Neurol       Date:  2018-04-21       Impact factor: 44.182

Review 6.  Gangliosides: glycosphingolipids essential for normal neural development and function.

Authors:  Cara-Lynne Schengrund
Journal:  Trends Biochem Sci       Date:  2015-05-01       Impact factor: 13.807

Review 7.  Gangliosides and Autoimmune Peripheral Nerve Diseases.

Authors:  John A Goodfellow; Hugh J Willison
Journal:  Prog Mol Biol Transl Sci       Date:  2018-03-28       Impact factor: 3.622

8.  Pediatric Miller Fisher Syndrome Complicating an Epstein-Barr Virus Infection.

Authors:  Céline Communal; Anne Filleron; Sandrine Baron-Joly; Randa Salet; Tu-Anh Tran
Journal:  Pediatr Neurol       Date:  2016-06-27       Impact factor: 3.372

9.  A Case of Miller Fisher Syndrome and Literature Review.

Authors:  Sumera Bukhari; Javier Taboada
Journal:  Cureus       Date:  2017-02-22

Review 10.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

View more
  3 in total

Review 1.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

2.  Clinical and antibodies analysis of anti-GQ1b antibody syndrome: a case series of 15 patients.

Authors:  Xiaohui Wu; Yuzhu Wang; Zhi-Qin Xi
Journal:  Acta Neurol Belg       Date:  2022-04-11       Impact factor: 2.396

3.  Miller Fisher Syndrome Presenting Without Areflexia, Ophthalmoplegia, and Albuminocytological Dissociation: A Case Report.

Authors:  Mohammad R Ghani; Muhammad Ismail Khalid Yousaf; Kelly Van Bussum; Ping Shi; Rolando M Cordoves Feria; Martin Brown
Journal:  Cureus       Date:  2022-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.